adefovir has been researched along with s 8932 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmohsen, UR; Abdelwahab, GM; Ali, MA; El-Metwally, MEA; ElNaggar, MH; GabAllah, M; Khalil, AT; Kutkat, O; Sayed, AM | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for adefovir and s 8932
| Article | Year |
|---|---|
Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Aspergillus niger; Chlorocebus aethiops; Chromones; Coronavirus 3C Proteases; Coronavirus Papain-Like Proteases; Coronavirus RNA-Dependent RNA Polymerase; Molecular Docking Simulation; Protease Inhibitors; RNA Helicases; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells | 2022 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |